Drugs / Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03751631 | Nov 2018 → Jan 2019 | — | Eyenovia Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03751631 ↗ |
| Known as | TR/PE | “Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)” NCT03751631 ↗ |